Ananth Rao talks passionately about his ambition of being a top-level gymnast just like his hero, Commonwealth Games gold medallist Ashish Kumar.
Every few minutes though, the 24-year-old Mysore lad pauses to express repressed sorrow. But there are no tears, just a hint of regret on his pained face as he recollects the fateful day when his dreams were cruelly snuffed out.
Ananth, like any other budding gymnast, was eager to impress at the Dasara Games in September 2010 when the state-level star mistimed a somersault during a practice routine.
Ananth’s head crashed on to the mat and he heard
Scientific inspiration can come from anywhere — a person, an event, even an experiment gone awry. But perhaps nothing can drive innovation more powerfully than the passion born of tragedy. Or, in Douglas Melton’s case, near tragedy. The co-director of the Harvard Stem Cell Institute (HSCI) is one of the leading figures in the search for cures for presently incurable diseases, and his breakthrough work is challenging many long-held beliefs about the ways biology and human development work.
But it was a very personal experience that brought Melton to stem cells, one that 17 years later he still finds difficult
An Iranian scientist managed to develop a new method to propagate human spermatogonial stem cells from small testicular biopsies to obtain adequate number of cells for successful transplantation for 18000-fold in vitro, leading to protection of the fertility of immature boys suffering from cancer.
The research carried out jointly with Amsterdam University in Holland is the first developed method in the world.
Hooman Sadri-Ardekani, Ph.D in Reproductive Medicine and a Professor in Avicenna Institute-ACECR told ISNA, “Young boys treated with high-dose chemotherapy are often confronted with infertility once they reach adulthood and cryopreserving testicular tissue before chemotherapy and auto transplantation of
Warnings are being issued by experts of the dangers of medical tourism saying that unproven stem cell therapy overseas could leave patients worse off.
Signing up for stem cell therapy is worth the risk for many people who are suffering with conditions like spinal injury, multiple sclerosis, motor neuron or Parkinson’s disease.
A medical journal reported earlier this year that an Israeli teenager developed brain tumors after experimental injections at a Russian clinic.
There are alternate reports also of patients contracting meningitis after treatments in China.
A handbook will be released by the Australian Stem Cell Centre to help patients analyze radial stem
Image via Wikipedia
First and foremost, the new international guidelines on stem cells, with four Italians among the authors, need to be clear, eliminating false illusions, incredible exaggerations, and confusion due to excess emphasis placed on the therapeutic properties of adult stem cells compared to embryonic stem cells.
The International Society for Stem Cell Research (ISSCR) has decided to impart some order in a field of research which, for various reasons, is growingly involved in issues that have little to do with research.
“Regulation is necessary,” according to the Society, commenting about studies that risk creating exaggerated controversy or omitting risks regarding